| Multifactorial processes underlie parallel opsin loss in neotropical bats A Sadier, KTJ Davies, LR Yohe, K Yun, P Donat, BP Hedrick, ER Dumont, ... Elife 7, e37412, 2018 | 46 | 2018 |
| A novel mouse AAV6 hACE2 transduction model of wild-type SARS-CoV-2 infection studied using synDNA immunogens EN Gary, BM Warner, EM Parzych, BD Griffin, X Zhu, N Tailor, NJ Tursi, ... iscience 24 (7), 2021 | 15 | 2021 |
| DNA immunotherapy targeting BARF1 induces potent anti-tumor responses against Epstein-Barr-virus-associated carcinomas X Zhu, A Perales-Puchalt, K Wojtak, Z Xu, K Yun, PS Bhojnagarwala, ... Molecular Therapy-Oncolytics 24, 218-229, 2022 | 5 | 2022 |
| Synthetic DNA Vaccines Adjuvanted with pIL-33 Drive Liver-Localized T Cells and Provide Protection from Plasmodium Challenge in a Mouse Model SM Reeder, EL Reuschel, MA Bah, K Yun, NJ Tursi, KY Kim, J Chu, ... Vaccines 8 (1), 21, 2020 | 5 | 2020 |
| DNA-encoded glutamine synthetase enzyme as ammonia-lowering therapeutic for hyperammonemia M Khoshnejad, Y Dia, A Patel, Z Xu, X Zhu, K Yun, K Wojtak, R Qureshi, ... nucleic acid therapeutics 30 (6), 379-391, 2020 | 3 | 2020 |
| Evidence for multifactorial processes underlying phenotypic variation in bat visual opsins A Sadier, KTJ Davies, LR Yohe, K Yun, P Donat, BP Hedrick, ER Dumont, ... bioRxiv, 300301, 2018 | 3 | 2018 |
| Synthetic DNA Delivery of an Engineered Arginase Enzyme Can Modulate Specific Immunity In Vivo M Khoshnejad, A Perales-Puchalt, Y Dia, P Xiao, A Patel, Z Xu, X Zhu, ... Molecular Therapy Methods & Clinical Development 18, 652-663, 2020 | 2 | 2020 |
